Document is current
Any future updates will be listed below
-
Authors
Desai, Neelam V.
Torous, Vanda
Parker, Joel
Auman, James T.
Rosson, Gary B.
Cruz, Cassandra
Perou, Charles M.
Schnitt, Stuart J.
Tung, Nadine
-
Funding
Funding for this research was provided by:
Division of Cancer Epidemiology and Genetics, National Cancer Institute (P50-CA58223)
Susan G. Komen (SAC-160074)
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
First Online: 11 July 2018
Ethics approval and consent to participate
: This study was approved by the Dana-Farber/Harvard Cancer Center IRB. The IRB protocol number is DFCI Protocol No. 17–054.
: Not applicable.
: CMP is an equity stock holder, consultant, and Board of Director Member of BioClassifier LLC. CMP is also listed as an inventor on patent applications on the Breast PAM50 Subtyping assay. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
